Rosemary J. Akhurst earned a First Class BSc (Hons) in Biochemistry from Imperial College London (1978) and a PhD in Molecular Biology from the Beatson Institute for Cancer Research, Glasgow (1981). She is currently Professor of Anatomy, based in the Helen Diller Family Comprehensive Cancer Center, UCSF, in San Francisco, where she serves as Principal Investigator on multiple NIH-funded projects. Her work in cancer biology has resulted in prestigious awards, including the EMBO Fellowship (1982-1984) and UCSF Mentoring Award (2020), and foundational discoveries in TGFβ signaling pathways affecting vascular biology and tumor progression. Her leadership roles include Director of the HDFCCC Preclinical Therapeutics Shared Resource and Vice-Chair of CureHHT's Global Research and Medical Advisory Board (2019-2025). Her research topics include the development of oncology drug resistance, cancer immunotherapy targets, vascular stability and pathobiology, and reducing cancer health disparities through translational research. Professor Akhurst continues to bridge molecular discoveries with clinical applications while mentoring next-generation scientists through UCSF's Biomedical Sciences Program.